Richmond C Bradford

Director Richmond C Bradford buys 1,000 BJRI shares at $34.05 amid -20.9% 30-day decline

Richmond C Bradford, a director, purchased 1,000 shares at $34.05 on 2026-03-12, increasing his holdings from 17,700 to 18,700 shares. The purchase occurs as BJRI trades at $33.73, down 20.9% over the past 30 days and 27.9% from its 52-week high of $46.78, placing the stock in a sharply depressed price regime relative to recent history. Bradford's same-ticker history shows 5 prior trades, including two measurable buy outcomes from September 2024 that posted +19.2% and +17.2% 30-day returns respectively, though the three most recent purchases on 2026-03-06 and 2026-03-03 lack outcome data. His cross-ticker track record demonstrates a 100% 90-day win rate across 5 prior buys with average 90-day returns of +24.5%, establishing a pattern of well-timed entries. The company maintains modest fundamentals with $330.2M quarterly revenue, $465.0K net income, and a P/E of 11.36, suggesting limited growth expectations in the current backdrop.

Director Richmond C Bradford bought 1,000 shares of BJRI at $34.50 on 2026-03-06; holdings now 17,700 shares (+6.0%)

Director Richmond C Bradford purchased 1,000 shares at $34.50 on 2026-03-06, increasing his holdings to 17,700 shares from 16,700 shares pre-transaction. This transaction occurs while the stock trades at $35.18, down 24.8% from its 52-week high of $46.78 and down 21.1% over the prior 30 days. Bradford's track record across his prior buys shows an average 90-day return of +24.5% with a 100.00% win rate, and at BJRI specifically, his prior two measurable purchases in 2024-09-06 delivered 90-day returns of +25.6% and +23.5%, establishing a pattern of well-timed buys at this ticker. The company's fundamentals show Q revenue of $330.2M with a P/E of 11.85, and Bradford's recent accumulation—two buys on 2026-03-03 immediately preceding this 2026-03-06 purchase—aligns with his demonstrated timing skill at this issuer during a period of recent price weakness.

Director Richmond C Bradford buys 1,200 shares at blended $35.10; stock down 23.4% from 52-week high and 18.3% in 30 days.

Richmond C Bradford, Director, executed 2 separate purchases totaling 1,200 shares for $42,122.00, increasing holdings from 15,500 to 16,700 shares. The buys occurred at $35.05 and $35.36 on March 3, 2026, when the stock was trading -23.4% from its 52-week high and down 18.3% over the prior 30 days. Bradford's track record across all tickers shows 2 prior buys with an average 90-day return of +24.5% and a 100% win rate; at BJRI specifically, his prior 2 buys (September 2024) each posted strong 90-day returns (+25.6% and +23.5%). The timing pattern in his BJRI history shows both prior purchases were followed by gains at the 90-day mark. The company's fundamentals show a P/E of 12.06, recent quarterly revenue of $330.2M, and 3.1% annual revenue growth, suggesting moderate valuation. This purchase occurs during a period of notable recent price weakness.

Interim CEO Richmond C Bradford purchases 2,500 shares of BJRI at blended $29.40 average, bringing holdings to 16,905 shares

Interim CEO Richmond C Bradford executed two separate purchases totaling 2,500 shares for $73,500.00 on 2024-09-06 at prices of $29.10 and $29.60, increasing his holdings by 17.4% from 14,405 shares to 16,905 shares. The transactions occurred at prices near current levels ($29.52), within the 52-week range of $21.99–$38.13 but at a discount to the 52-week high of $38.13. For an interim CEO—a role typically filled during transitional periods—the acquisition warrants attention as a data point on insider behavior during leadership uncertainty, though interim tenure itself constrains inferences about conviction or long-term positioning relative to a permanent executive. The stock's 90-day decline of -13.5% and P/E of 23.43 provide market context but do not independently justify or contextualize the timing of this purchase.